Affiliation:
1. Department of Clinical Laboratory Jiaozhou Central Hospital Qingdao Shandong China
2. Department of Prevention of Infectious Diseases Xi'an Center for Disease Control and Prevention Xi'an Shaanxi China
3. Institute for Prevention and Control of Viral Diseases Shaanxi Provincial Center for Disease Control and Prevention Xi'an Shaanxi China
4. Department of Epidemiology, Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health Air Force Medical University Xi'an Shaanxi China
5. Department of Surgery Emergency, Jiaozhou Hospital East Hospital Affiliated to Tongji University Qingdao Shandong China
Abstract
AbstractAcute gastroenteritis outbreaks may be caused by the excretion of norovirus (NoV) from asymptomatic individuals. Despite numerous studies involving asymptomatic NoV infection during outbreaks in China, a comprehensive assessment of its role has not been conducted, which is critical for emergency management. Our objective was to assess the prevalence of asymptomatic NoV infection during outbreaks in China. We conducted a comprehensive search of multiple databases, including PubMed, Web of Science, Cochrane Library, China National Knowledge Infrastructure, China Wanfang, and China Weipu, between January 1, 1997 and June 19, 2023. The retrieved articles and their references underwent screening, which utilized polymerase chain reaction‐based assays for the detection of NoV in asymptomatic individuals during outbreaks that occurred in China. The primary summary data were the prevalence of asymptomatic NoV infection in outbreaks. We generated pooled estimates of asymptomatic prevalence in the population as a whole and in subgroups by using random‐effect models. Of the 97 articles included, the pooled asymptomatic prevalence of NoV among 5117 individuals in outbreaks was 17.6% (95% confidence interval [CI]: 14.1–21.3). The asymptomatic prevalence of NoV GII (17.1%, 95% CI: 12.9–21.5) was similar to that of NoV GI (22.0%, 95% CI: 12.8–32.4). However, the proportion of asymptomatic individuals involved in NoV GII (57.44%) was significantly higher than that of NoV GI (5.12%), and NoV GII (75.26%) was reported much more frequently than NoV GI (14.43%) in the included articles. Meta‐regression analysis of 11 possible influencing factors (geographic region, setting, season, sample type, genotype, transmission route, occupation, age, per capita income, study quality, and cases definition) showed that the source of heterogeneity might be related to the outbreak settings, per capita income, and study quality (p = 0.037, 0.058, and 0.026, respectively). Of particular note was the asymptomatic prevalence peaked in preschoolers (27.8%), afterward, it fell into trough in elementary and junior school children (10.5%), before the second peak located in adults (17.8%), and the elderly (25.2%). Prevalent genotypes reported include GII.4, followed by GII.17, GII.2, GII.3, GII.6, and so forth. The estimated asymptomatic prevalence of NoV during outbreaks in China was as high as 17.6%, with NoV GII dominating. In addition, genetic subtypes of NoV in outbreaks should be detected whenever possible. The role of asymptomatic individuals in NoV outbreaks cannot be ignored. This knowledge will help governments develop public health policies and emergency response strategies for outbreaks, assess the burden, and develop vaccines.
Reference48 articles.
1. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis
2. Updated norovirus outbreak management and disease prevention guidelines;Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention;Morbid Mortal Week Rep Recomm Rep,2011
3. Norovirus: An Overview of Virology and Preventative Measures
4. Centres for Disease Control and Prevention. Norovirus Burden and Trends. May 8 2023. Accessed October 21 2023.https://www.cdc.gov/norovirus/burden.html#worldwide
5. Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献